Loading, please wait ...

News Analytics

gilead logo.
-- Largest Analysis Examining Use of CAR T-cell Therapy Across Race and Ethnicity -- -- Black or African American Patients Experienced Longer Time from Diagnosis to Infusion Compared to White Patients, Possibly Impacting Overall and Complete Response Rates; More Study Warranted -- -- Clinical Trials of Yescarta in the U.S. and Real-World Use from CIBMTR Registry Show Consistent Participation ...

The Angle

Subject Matter

  • Healthcare 72.31%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 27.69%

Emotional Reaction






Depth Chart

Here we provide depth for the multitude of dimensions lacing this article.

Connect your favorite information below with the lead sentence at the top of the page to build a mental model of the story.